|
2961 |
Tight-Control der Entzündungsaktivität in der Therapie der frühen Psoriasisarthritis
Enthalten in Zeitschrift für Rheumatologie Bd. 75, 14.11.2016, Nr. 10, date:12.2016: 1032-1034
|
|
|
|
2962 |
Tissue engineering-relevant characteristics of ex vivo and monolayer-expanded chondrocytes from the notch versus trochlea of human knee joints
Enthalten in International orthopaedics Bd. 41, 21.8.2017, Nr. 11, date:11.2017: 2327-2335
|
|
|
|
2963 |
TNF-α-induced miR-155 regulates IL-6 signaling in rheumatoid synovial fibroblasts
Enthalten in Biomed Central (London): BMC Research Notes Bd. 10, 14.8.2017, Nr. 1, date:12.2017: 1-6
|
|
|
|
2964 |
TNF inhibitors/methotrexate/rituximab
Enthalten in Reactions weekly Bd. 1650, 6.5.2017, Nr. 1, date:5.2017: 270
|
|
|
|
2965 |
TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis
Enthalten in Clinical rheumatology Bd. 36, 23.6.2017, Nr. 10, date:10.2017: 2243-2251
|
|
|
|
2966 |
TNT-Kongress
Enthalten in Orthopädie und Unfallchirurgie Bd. 8, 12.2.2018, Nr. 1, date:2.2018: 76-77
|
|
|
|
2967 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1653, 27.5.2017, Nr. 1, date:5.2017: 293
|
|
|
|
2968 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1653, 27.5.2017, Nr. 1, date:5.2017: 294
|
|
|
|
2969 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1663, 5.8.2017, Nr. 1, date:8.2017: 289
|
|
|
|
2970 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1664, 12.8.2017, Nr. 1, date:8.2017: 274
|
|
Administration
